RAPT Therapeutics Inc (RAPT)
1.67
+0.04
(+2.45%)
USD |
NASDAQ |
Jan 03, 16:00
1.68
+0.01
(+0.60%)
After-Hours: 20:00
RAPT Therapeutics Enterprise Value: -39.52M for Jan. 3, 2025
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| AbbVie Inc | 384.07B |
| Biomarin Pharmaceutical Inc | 12.40B |
| Arbutus Biopharma Corp | 520.27M |
| Assembly Biosciences Inc | 16.22M |
| GlycoMimetics Inc | 3.470M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -18.43M |
| Total Expenses (Quarterly) | 19.79M |
| EPS Diluted (Quarterly) | -0.47 |
| Earnings Yield | -166.5% |
| Normalized Earnings Yield | -152.69 |